Life360, Inc. SEC Filings

Life360, Inc. (LIF) insider transaction summary: Chief Executive Officer and Director Lauren Antonoff sold 17,764 shares of Life360 common stock on 09/05/2025 at an average reported price of $90.903 per share. The Form 4 states the sale was a "sell-to-cover" to satisfy tax withholding obligations tied to the vesting and settlement of previously granted restricted stock units (RSUs). After the transaction Antonoff beneficially owned 338,465 shares, which the filing notes includes 222,277 unvested RSUs that convert to one share each upon vesting. The Form 4 was signed by an attorney-in-fact on 09/08/2025.

Life360, Inc. insider transaction by CFO John Burke: On 09/04/2025 the reporting person, John Burke (Chief Financial Officer), had 9,976 shares withheld at a price of $86.65 to satisfy income tax withholding in connection with the vesting and net settlement of previously granted restricted stock units. After this withholding, the filing shows Mr. Burke beneficially owns 101,255 shares directly and 63,030 shares indirectly (held by the Russell John Burke Revocable Trust). The form notes there are 91,732 restricted stock units previously granted that represent contingent rights to receive common stock upon vesting.

Form 144 filed for Life360, Inc. (LIF) reporting a proposed sale of 17,764 common shares through Fidelity Brokerage Services with an aggregate market value of $1,614,806.22, and an approximate sale date of 09/05/2025 on NASDAQ. The filing states these shares were acquired by restricted stock vesting from the issuer and that payment is compensation. The filing also discloses four prior dispositions by the same seller in the past three months totaling 32,446 shares for gross proceeds of $2,252,183.02. The notice includes the seller's representation that they are not aware of any undisclosed material adverse information.

Life360 director John Philip Coghlan reported sales of common stock under a Rule 10b5-1 plan on 09/02/2025. The Form 4 shows two reported sale groupings: 508 shares sold at a weighted average price of $87.03 (individual trades ranged $86.50–$87.49) and 2,617 shares sold at a weighted average price of $88.33 (individual trades ranged $87.74–$88.71).

After these transactions the reporting person beneficially owned 11,992 shares held by the John Coghlan Living Trust and 9,375 shares held by the same trust, plus 67,604 shares held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust. The filings note 3,344 restricted stock units that convert to shares upon vesting. The sales were effected pursuant to a 10b5-1 plan adopted December 6, 2024.

Life360, Inc. reporting person Lauren Antonoff, who serves as Chief Executive Officer and a director, received a grant of 52,997 restricted stock units (RSUs) on 09/01/2025. Each RSU converts to one share upon settlement and the grant vests monthly at a rate of 1/48th beginning September 1, 2025, subject to continued service. Following the grant, the filing reports 356,229 shares/RSU-equivalents beneficially owned, which includes 258,971 previously granted RSUs. The acquisition was recorded at a $0 price (typical for RSU grants). The Form 4 was signed by an attorney-in-fact on 09/03/2025.

Life360 director Chris Hulls received a grant of 26,499 restricted stock units (RSUs) that vest monthly over four years. Each RSU converts into one share upon settlement and 1/48th vests monthly beginning 09/01/2025, subject to continuous service. After the grant the reporting person beneficially owns 483,830 shares (including previously granted RSUs).

The filing discloses 151,934 previously granted RSUs, ownership through three family irrevocable trusts and a minority interest in ICCA Labs, LLC, and that 585,938 CDIs remain subject to a lock-up agreement.

Life360, Inc. (LIF) director Mark Goines received a grant of 189 Restricted Stock Units (RSUs) on 09/01/2025. Each RSU vests into one share on settlement; one-third vests on November 15, 2025, and the remaining two-thirds vest in equal quarterly installments thereafter, subject to continuous service. The reported RSUs were granted at a $0 price. After the reported transaction, the filing shows 6,070 shares beneficially owned directly and 71,809 shares held indirectly by the Goines Wong Living Trust. The filing also notes 3,055 previously granted RSUs included in the totals.

Life360, Inc. (LIF) Form 4: This filing reports insider transactions by John Burke Russell, identified as the companys Chief Financial Officer. On 08/26/2025 the reporting person sold 16,287 shares of common stock at a weighted-average price of $90.42 per share (individual trade prices ranged from $90.07 to $90.72). After the sale, the filing shows 63,030 shares beneficially owned indirectly, held by the Russell John Burke Revocable Trust. The filing also notes a prior transfer of 79,317 directly held shares to that trust, which the filer states was exempt from Section 16 under Rule 16a-13. Additionally, 111,231 restricted stock units remain recorded as contingent rights to receive common stock upon vesting. The form is signed by Allison Chang, Attorney-in-Fact, dated 08/28/2025.

Life360 insider sale by CEO/director Lauren Antonoff. The filing shows Ms. Antonoff sold 4,546 shares of Life360 common stock on 08/25/2025 at $90 per share under a pre-established Rule 10b5-1 trading plan adopted 11/27/2024. After the sale, she beneficially owns 303,232 shares, which includes 205,974 restricted stock units that convert to common shares upon vesting. The Form 4 was signed by an attorney-in-fact on 08/27/2025. The filing states the 10b5-1 plan was adopted when the reporting person was unaware of any material nonpublic information.